On Monday, January 19, the next meeting of the AOTMiT Transparency Council.
AOTMiT: Transparency Council on menopause, vaccinations and insomnia, among others
Published Jan. 16, 2026 07:25
Agenda:
- Preparation of a position paper on the qualification of the healthcare benefit
"ABI - measurement of the ankle-arm index - non-invasive test". - Preparation of a position paper on the evaluation of the drug Coatoris
(ezetimibum + atorvastatinum) in the indications:
- prevention of cardiovascular incidents,
- hypercholesterolemia,
- homozygous familial hypercholesterolemia. - Preparation of a position paper on the evaluation of the drug Keytruda (pembrolizumab)
within the framework of the drug program B.58
"Treatment of patients with cancer of the esophagus, gastroesophageal junction and stomach
(ICD-10: C15-C16) (HER2+)". - Preparation of a position paper on the examination of the legitimacy of issuing
approvals for reimbursement of the medicinal product Quviviq (daridorexantum)
for the indication: inorganic insomnia, in case of ineffectiveness and/or
intolerance of alternative drug technologies available on the Polish market
for an individual patient. - Preparation of an opinion on the draft health policy program of the local government unit
"Support of female residents of Wroclaw during menopause:
MENOPAUZA - health, satisfaction, maturity!". - Preparation of an opinion on the draft health policy program of the local government unit
"Pertussis vaccination program targeting adults
in the Piaseczyn district for 2026-2028". - Preparation of an opinion on the draft health policy program of the local government unit
"Prevention and rehabilitation of postural defects in students of classes I-IV of elementary schools
in the Municipality of Siechnice in 2026-2027". - Preparation of an opinion on the draft health policy program of a local government unit
"Program of prevention of hemiplegia and hemiplegic neuralgia
in the population of people aged 55 and over" (Opole).
Source: AOTMiT
Topics
bezsenność / menopauza / krztusiec / szczepienia dorosłych / Rada Przejrzystości AOTMiT / rak przełyku








